abemaciclib,ribociclib
eli lilly,novartis
['abema', 'breast', ' ribo', 'abemaciclib', 'ribociclib']
depending upon approval and access - potentially we will have two cd k 4/6 inhibitors in early stage er+ her-2 negative #breastcancer #asco23 with broader inclusion criteria for ribociclib, but with longer follow up for abemaciclib! 
Prof. & Chair Dept. of Heme & Oncology @CleClinicMD @ClevelandClinic @NRGonc Deputy Editor @JCOOP_ASCO Tweets are mine. No act of #Kindness is ever wasted!